Literature DB >> 203057

Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins.

D E MacIntyre, J L Gordon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 203057     DOI: 10.1016/0049-3848(77)90099-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

1.  Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.

Authors:  D E MacIntyre; E W Salzman; J L Gordon
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

2.  AH6809, a prostaglandin DP-receptor blocking drug on human platelets.

Authors:  R J Keery; P Lumley
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

Review 3.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

4.  Trimethoquinol is a potent prostaglandin endoperoxide antagonist [proceedings].

Authors:  D E MacIntyre; A L Willis
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

5.  Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.

Authors:  S Hamid-Bloomfield; B J Whittle
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

Review 6.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

7.  The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.

Authors:  H Giles; P Leff; M L Bolofo; M G Kelly; A D Robertson
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

8.  Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.

Authors:  J S Matthews; R L Jones
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

9.  Ligand binding to thromboxane receptors on human platelets: correlation with biological activity.

Authors:  R A Armstrong; R L Jones; N H Wilson
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

10.  Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.

Authors:  S Hamid-Bloomfield; B J Whittle
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.